Business Wire

Advanced Radiation Centers of New York Pioneers the First Commercial U.S. Implantation of a Biodegradable Balloon Spacer That Will Revolutionize Radiation Therapy for Prostate ...

Physicians at medical practices affiliated with Solaris Health, the nation’s leading healthcare management company in the urological field, are the first throughout the country to provide a new ...
abc27

Long-Term Study Reports Sustained Quality of Life Benefits with the BioProtect Balloon Spacer in Prostate Cancer Radiation Therapy

BETHLEHEM, Pa., Nov. 7, 2025 /PRNewswire/ -- Following publication of BioProtect's pivotal randomized trial in the International Journal of Radiation Oncology, Biology, Physics (Red Journal) and ...
Business Insider

BioProtect Announces Final Closing of Equity Financing at $25M To Protect Prostate Cancer Patients

TZUR YIGAL, Israel, Sept. 21, 2020 /PRNewswire/ -- BioProtect ltd., a private company with a unique bioabsorbable polymer spacer balloon platform, announced the final closing of $25 million of its ...
MD&M East

BioProtect Nabs $28M for Balloon Implant System Commercialization

BioProtect, a company providing biodegradable spacing solutions, recently announced it closed its most recent funding round with $28 million from investors. The round was led by MVM Partners, with ...
Business Insider

BioProtect Notes Completion of Patient Enrollment for its IDE Pivotal Study of the ProSpace™ Balloon Spacer

TZUR IGAL, Israel, June 15, 2021 /PRNewswire/ -- BioProtect Ltd., a private commercial-stage medical device company, announced today that the company has enrolled all the planned patients in the ...